Efficient Production of rAAV in a Perfusion Bioreactor Using an ELEVECTA® Stable Producer Cell Line

Genetic Engineering & Biotechnology NewsVol. 41, No. S2 Sponsored ContentEfficient Production of rAAV in a Perfusion Bioreactor Using an ELEVECTA® Stable Producer Cell LineJuliana Coronel, Aishwarya Patil, Ahmad Al-Dali, Thomas Braβ, Nicole Faust, and Silke WissingJuliana CoronelCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this author, Aishwarya PatilCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this author, Ahmad Al-DaliCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this author, Thomas BraβCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this author, Nicole FaustCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this author, and Silke WissingCEVEC Pharmaceuticals GmbH, Cologne, GermanySearch for more papers by this authorPublished Online:6 Apr 2021https://doi.org/10.1089/gen.41.S2.07AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 41Issue S2Apr 2021 InformationCopyright © GEN PublishingTo cite this article:Juliana Coronel, Aishwarya Patil, Ahmad Al-Dali, Thomas Braβ, Nicole Faust, and Silke Wissing.Efficient Production of rAAV in a Perfusion Bioreactor Using an ELEVECTA® Stable Producer Cell Line.Genetic Engineering & Biotechnology News.Apr 2021.S23-S23.http://doi.org/10.1089/gen.41.S2.07Published in Volume: 41 Issue S2: April 6, 2021PDF download